Global Newborn Genetic Screening Market 2023 by Company, Regions, Type and Application, Forecast to 2029

  • receipt Report ID : 143894
  • calendar_today Published On: Feb, 2023
  • file_copy Pages: 165
  • list Services
Buy @ $3500

According to our latest study, the global Newborn Genetic Screening market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Newborn Genetic Screening market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

Global Newborn Genetic Screening market size and forecasts, in consumption value ($ Million), 2018-2029

Global Newborn Genetic Screening market size and forecasts by region and country, in consumption value ($ Million), 2018-2029

Global Newborn Genetic Screening market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029

Global Newborn Genetic Screening market shares of main players, in revenue ($ Million), 2018-2023

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Newborn Genetic Screening

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Newborn Genetic Screening market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Trivitron Healthcare, MASIMO CORPORATION, Covidien Plc, Nemours KidsHealth and NJ.gov, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation

Newborn Genetic Screening market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type

Dry blood spot tests

Hearing screening tests

CCHD screening tests

Market segment by Application

Clinical Laboratories

Hospitals

Market segment by players, this report covers

Trivitron Healthcare

MASIMO CORPORATION

Covidien Plc

Nemours KidsHealth

NJ.gov

Agilent Technologies

Ge Healthcare

PERKINELMER

Natus Medical Incorporated

Waters

Bio-Rad Laboratories

Ab Sciex LLC

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)

South America (Brazil, Argentina and Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Newborn Genetic Screening product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of Newborn Genetic Screening, with revenue, gross margin and global market share of Newborn Genetic Screening from 2018 to 2023.

Chapter 3, the Newborn Genetic Screening competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Newborn Genetic Screening market forecast, by regions, type and application, with consumption value, from 2024 to 2029.

Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War

Chapter 12, the key raw materials and key suppliers, and industry chain of Newborn Genetic Screening.

Chapter 13, to describe Newborn Genetic Screening research findings and conclusion.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Newborn Genetic Screening

1.2 Market Estimation Caveats and Base Year

1.3 Classification of Newborn Genetic Screening by Type

1.3.1 Overview: Global Newborn Genetic Screening Market Size by Type: 2018 Versus 2022 Versus 2029

1.3.2 Global Newborn Genetic Screening Consumption Value Market Share by Type in 2022

1.3.3 Dry blood spot tests

1.3.4 Hearing screening tests

1.3.5 CCHD screening tests

1.4 Global Newborn Genetic Screening Market by Application

1.4.1 Overview: Global Newborn Genetic Screening Market Size by Application: 2018 Versus 2022 Versus 2029

1.4.2 Clinical Laboratories

1.4.3 Hospitals

1.5 Global Newborn Genetic Screening Market Size & Forecast

1.6 Global Newborn Genetic Screening Market Size and Forecast by Region

1.6.1 Global Newborn Genetic Screening Market Size by Region: 2018 VS 2022 VS 2029

1.6.2 Global Newborn Genetic Screening Market Size by Region, (2018-2029)

1.6.3 North America Newborn Genetic Screening Market Size and Prospect (2018-2029)

1.6.4 Europe Newborn Genetic Screening Market Size and Prospect (2018-2029)

1.6.5 Asia-Pacific Newborn Genetic Screening Market Size and Prospect (2018-2029)

1.6.6 South America Newborn Genetic Screening Market Size and Prospect (2018-2029)

1.6.7 Middle East and Africa Newborn Genetic Screening Market Size and Prospect (2018-2029)

2 Company Profiles

2.1 Trivitron Healthcare

2.1.1 Trivitron Healthcare Details

2.1.2 Trivitron Healthcare Major Business

2.1.3 Trivitron Healthcare Newborn Genetic Screening Product and Solutions

2.1.4 Trivitron Healthcare Newborn Genetic Screening Revenue, Gross Margin and Market Share (2018-2023)

2.1.5 Trivitron Healthcare Recent Developments and Future Plans

2.2 MASIMO CORPORATION

2.2.1 MASIMO CORPORATION Details

2.2.2 MASIMO CORPORATION Major Business

2.2.3 MASIMO CORPORATION Newborn Genetic Screening Product and Solutions

2.2.4 MASIMO CORPORATION Newborn Genetic Screening Revenue, Gross Margin and Market Share (2018-2023)

2.2.5 MASIMO CORPORATION Recent Developments and Future Plans

2.3 Covidien Plc

2.3.1 Covidien Plc Details

2.3.2 Covidien Plc Major Business

2.3.3 Covidien Plc Newborn Genetic Screening Product and Solutions

2.3.4 Covidien Plc Newborn Genetic Screening Revenue, Gross Margin and Market Share (2018-2023)

2.3.5 Covidien Plc Recent Developments and Future Plans

2.4 Nemours KidsHealth

2.4.1 Nemours KidsHealth Details

2.4.2 Nemours KidsHealth Major Business

2.4.3 Nemours KidsHealth Newborn Genetic Screening Product and Solutions

2.4.4 Nemours KidsHealth Newborn Genetic Screening Revenue, Gross Margin and Market Share (2018-2023)

2.4.5 Nemours KidsHealth Recent Developments and Future Plans

2.5 NJ.gov

2.5.1 NJ.gov Details

2.5.2 NJ.gov Major Business

2.5.3 NJ.gov Newborn Genetic Screening Product and Solutions

2.5.4 NJ.gov Newborn Genetic Screening Revenue, Gross Margin and Market Share (2018-2023)

2.5.5 NJ.gov Recent Developments and Future Plans

2.6 Agilent Technologies

2.6.1 Agilent Technologies Details

2.6.2 Agilent Technologies Major Business

2.6.3 Agilent Technologies Newborn Genetic Screening Product and Solutions

2.6.4 Agilent Technologies Newborn Genetic Screening Revenue, Gross Margin and Market Share (2018-2023)

2.6.5 Agilent Technologies Recent Developments and Future Plans

2.7 Ge Healthcare

2.7.1 Ge Healthcare Details

2.7.2 Ge Healthcare Major Business

2.7.3 Ge Healthcare Newborn Genetic Screening Product and Solutions

2.7.4 Ge Healthcare Newborn Genetic Screening Revenue, Gross Margin and Market Share (2018-2023)

2.7.5 Ge Healthcare Recent Developments and Future Plans

2.8 PERKINELMER

2.8.1 PERKINELMER Details

2.8.2 PERKINELMER Major Business

2.8.3 PERKINELMER Newborn Genetic Screening Product and Solutions

2.8.4 PERKINELMER Newborn Genetic Screening Revenue, Gross Margin and Market Share (2018-2023)

2.8.5 PERKINELMER Recent Developments and Future Plans

2.9 Natus Medical Incorporated

2.9.1 Natus Medical Incorporated Details

2.9.2 Natus Medical Incorporated Major Business

2.9.3 Natus Medical Incorporated Newborn Genetic Screening Product and Solutions

2.9.4 Natus Medical Incorporated Newborn Genetic Screening Revenue, Gross Margin and Market Share (2018-2023)

2.9.5 Natus Medical Incorporated Recent Developments and Future Plans

2.10 Waters

2.10.1 Waters Details

2.10.2 Waters Major Business

2.10.3 Waters Newborn Genetic Screening Product and Solutions

2.10.4 Waters Newborn Genetic Screening Revenue, Gross Margin and Market Share (2018-2023)

2.10.5 Waters Recent Developments and Future Plans

2.11 Bio-Rad Laboratories

2.11.1 Bio-Rad Laboratories Details

2.11.2 Bio-Rad Laboratories Major Business

2.11.3 Bio-Rad Laboratories Newborn Genetic Screening Product and Solutions

2.11.4 Bio-Rad Laboratories Newborn Genetic Screening Revenue, Gross Margin and Market Share (2018-2023)

2.11.5 Bio-Rad Laboratories Recent Developments and Future Plans

2.12 Ab Sciex LLC

2.12.1 Ab Sciex LLC Details

2.12.2 Ab Sciex LLC Major Business

2.12.3 Ab Sciex LLC Newborn Genetic Screening Product and Solutions

2.12.4 Ab Sciex LLC Newborn Genetic Screening Revenue, Gross Margin and Market Share (2018-2023)

2.12.5 Ab Sciex LLC Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Newborn Genetic Screening Revenue and Share by Players (2018-2023)

3.2 Market Share Analysis (2022)

3.2.1 Market Share of Newborn Genetic Screening by Company Revenue

3.2.2 Top 3 Newborn Genetic Screening Players Market Share in 2022

3.2.3 Top 6 Newborn Genetic Screening Players Market Share in 2022

3.3 Newborn Genetic Screening Market: Overall Company Footprint Analysis

3.3.1 Newborn Genetic Screening Market: Region Footprint

3.3.2 Newborn Genetic Screening Market: Company Product Type Footprint

3.3.3 Newborn Genetic Screening Market: Company Product Application Footprint

3.4 New Market Entrants and Barriers to Market Entry

3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

4.1 Global Newborn Genetic Screening Consumption Value and Market Share by Type (2018-2023)

4.2 Global Newborn Genetic Screening Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

5.1 Global Newborn Genetic Screening Consumption Value Market Share by Application (2018-2023)

5.2 Global Newborn Genetic Screening Market Forecast by Application (2024-2029)

6 North America

6.1 North America Newborn Genetic Screening Consumption Value by Type (2018-2029)

6.2 North America Newborn Genetic Screening Consumption Value by Application (2018-2029)

6.3 North America Newborn Genetic Screening Market Size by Country

6.3.1 North America Newborn Genetic Screening Consumption Value by Country (2018-2029)

6.3.2 United States Newborn Genetic Screening Market Size and Forecast (2018-2029)

6.3.3 Canada Newborn Genetic Screening Market Size and Forecast (2018-2029)

6.3.4 Mexico Newborn Genetic Screening Market Size and Forecast (2018-2029)

7 Europe

7.1 Europe Newborn Genetic Screening Consumption Value by Type (2018-2029)

7.2 Europe Newborn Genetic Screening Consumption Value by Application (2018-2029)

7.3 Europe Newborn Genetic Screening Market Size by Country

7.3.1 Europe Newborn Genetic Screening Consumption Value by Country (2018-2029)

7.3.2 Germany Newborn Genetic Screening Market Size and Forecast (2018-2029)

7.3.3 France Newborn Genetic Screening Market Size and Forecast (2018-2029)

7.3.4 United Kingdom Newborn Genetic Screening Market Size and Forecast (2018-2029)

7.3.5 Russia Newborn Genetic Screening Market Size and Forecast (2018-2029)

7.3.6 Italy Newborn Genetic Screening Market Size and Forecast (2018-2029)

8 Asia-Pacific

8.1 Asia-Pacific Newborn Genetic Screening Consumption Value by Type (2018-2029)

8.2 Asia-Pacific Newborn Genetic Screening Consumption Value by Application (2018-2029)

8.3 Asia-Pacific Newborn Genetic Screening Market Size by Region

8.3.1 Asia-Pacific Newborn Genetic Screening Consumption Value by Region (2018-2029)

8.3.2 China Newborn Genetic Screening Market Size and Forecast (2018-2029)

8.3.3 Japan Newborn Genetic Screening Market Size and Forecast (2018-2029)

8.3.4 South Korea Newborn Genetic Screening Market Size and Forecast (2018-2029)

8.3.5 India Newborn Genetic Screening Market Size and Forecast (2018-2029)

8.3.6 Southeast Asia Newborn Genetic Screening Market Size and Forecast (2018-2029)

8.3.7 Australia Newborn Genetic Screening Market Size and Forecast (2018-2029)

9 South America

9.1 South America Newborn Genetic Screening Consumption Value by Type (2018-2029)

9.2 South America Newborn Genetic Screening Consumption Value by Application (2018-2029)

9.3 South America Newborn Genetic Screening Market Size by Country

9.3.1 South America Newborn Genetic Screening Consumption Value by Country (2018-2029)

9.3.2 Brazil Newborn Genetic Screening Market Size and Forecast (2018-2029)

9.3.3 Argentina Newborn Genetic Screening Market Size and Forecast (2018-2029)

10 Middle East & Africa

10.1 Middle East & Africa Newborn Genetic Screening Consumption Value by Type (2018-2029)

10.2 Middle East & Africa Newborn Genetic Screening Consumption Value by Application (2018-2029)

10.3 Middle East & Africa Newborn Genetic Screening Market Size by Country

10.3.1 Middle East & Africa Newborn Genetic Screening Consumption Value by Country (2018-2029)

10.3.2 Turkey Newborn Genetic Screening Market Size and Forecast (2018-2029)

10.3.3 Saudi Arabia Newborn Genetic Screening Market Size and Forecast (2018-2029)

10.3.4 UAE Newborn Genetic Screening Market Size and Forecast (2018-2029)

11 Market Dynamics

11.1 Newborn Genetic Screening Market Drivers

11.2 Newborn Genetic Screening Market Restraints

11.3 Newborn Genetic Screening Trends Analysis

11.4 Porters Five Forces Analysis

11.4.1 Threat of New Entrants

11.4.2 Bargaining Power of Suppliers

11.4.3 Bargaining Power of Buyers

11.4.4 Threat of Substitutes

11.4.5 Competitive Rivalry

11.5 Influence of COVID-19 and Russia-Ukraine War

11.5.1 Influence of COVID-19

11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

12.1 Newborn Genetic Screening Industry Chain

12.2 Newborn Genetic Screening Upstream Analysis

12.3 Newborn Genetic Screening Midstream Analysis

12.4 Newborn Genetic Screening Downstream Analysis

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Research Process and Data Source

14.3 Disclaimer

List of Tables

Table 1. Global Newborn Genetic Screening Consumption Value by Type, (USD Million), 2018 & 2022 & 2029

Table 2. Global Newborn Genetic Screening Consumption Value by Application, (USD Million), 2018 & 2022 & 2029

Table 3. Global Newborn Genetic Screening Consumption Value by Region (2018-2023) & (USD Million)

Table 4. Global Newborn Genetic Screening Consumption Value by Region (2024-2029) & (USD Million)

Table 5. Trivitron Healthcare Company Information, Head Office, and Major Competitors

Table 6. Trivitron Healthcare Major Business

Table 7. Trivitron Healthcare Newborn Genetic Screening Product and Solutions

Table 8. Trivitron Healthcare Newborn Genetic Screening Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 9. Trivitron Healthcare Recent Developments and Future Plans

Table 10. MASIMO CORPORATION Company Information, Head Office, and Major Competitors

Table 11. MASIMO CORPORATION Major Business

Table 12. MASIMO CORPORATION Newborn Genetic Screening Product and Solutions

Table 13. MASIMO CORPORATION Newborn Genetic Screening Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 14. MASIMO CORPORATION Recent Developments and Future Plans

Table 15. Covidien Plc Company Information, Head Office, and Major Competitors

Table 16. Covidien Plc Major Business

Table 17. Covidien Plc Newborn Genetic Screening Product and Solutions

Table 18. Covidien Plc Newborn Genetic Screening Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 19. Covidien Plc Recent Developments and Future Plans

Table 20. Nemours KidsHealth Company Information, Head Office, and Major Competitors

Table 21. Nemours KidsHealth Major Business

Table 22. Nemours KidsHealth Newborn Genetic Screening Product and Solutions

Table 23. Nemours KidsHealth Newborn Genetic Screening Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 24. Nemours KidsHealth Recent Developments and Future Plans

Table 25. NJ.gov Company Information, Head Office, and Major Competitors

Table 26. NJ.gov Major Business

Table 27. NJ.gov Newborn Genetic Screening Product and Solutions

Table 28. NJ.gov Newborn Genetic Screening Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 29. NJ.gov Recent Developments and Future Plans

Table 30. Agilent Technologies Company Information, Head Office, and Major Competitors

Table 31. Agilent Technologies Major Business

Table 32. Agilent Technologies Newborn Genetic Screening Product and Solutions

Table 33. Agilent Technologies Newborn Genetic Screening Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 34. Agilent Technologies Recent Developments and Future Plans

Table 35. Ge Healthcare Company Information, Head Office, and Major Competitors

Table 36. Ge Healthcare Major Business

Table 37. Ge Healthcare Newborn Genetic Screening Product and Solutions

Table 38. Ge Healthcare Newborn Genetic Screening Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 39. Ge Healthcare Recent Developments and Future Plans

Table 40. PERKINELMER Company Information, Head Office, and Major Competitors

Table 41. PERKINELMER Major Business

Table 42. PERKINELMER Newborn Genetic Screening Product and Solutions

Table 43. PERKINELMER Newborn Genetic Screening Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 44. PERKINELMER Recent Developments and Future Plans

Table 45. Natus Medical Incorporated Company Information, Head Office, and Major Competitors

Table 46. Natus Medical Incorporated Major Business

Table 47. Natus Medical Incorporated Newborn Genetic Screening Product and Solutions

Table 48. Natus Medical Incorporated Newborn Genetic Screening Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 49. Natus Medical Incorporated Recent Developments and Future Plans

Table 50. Waters Company Information, Head Office, and Major Competitors

Table 51. Waters Major Business

Table 52. Waters Newborn Genetic Screening Product and Solutions

Table 53. Waters Newborn Genetic Screening Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 54. Waters Recent Developments and Future Plans

Table 55. Bio-Rad Laboratories Company Information, Head Office, and Major Competitors

Table 56. Bio-Rad Laboratories Major Business

Table 57. Bio-Rad Laboratories Newborn Genetic Screening Product and Solutions

Table 58. Bio-Rad Laboratories Newborn Genetic Screening Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 59. Bio-Rad Laboratories Recent Developments and Future Plans

Table 60. Ab Sciex LLC Company Information, Head Office, and Major Competitors

Table 61. Ab Sciex LLC Major Business

Table 62. Ab Sciex LLC Newborn Genetic Screening Product and Solutions

Table 63. Ab Sciex LLC Newborn Genetic Screening Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 64. Ab Sciex LLC Recent Developments and Future Plans

Table 65. Global Newborn Genetic Screening Revenue (USD Million) by Players (2018-2023)

Table 66. Global Newborn Genetic Screening Revenue Share by Players (2018-2023)

Table 67. Breakdown of Newborn Genetic Screening by Company Type (Tier 1, Tier 2, and Tier 3)

Table 68. Market Position of Players in Newborn Genetic Screening, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022

Table 69. Head Office of Key Newborn Genetic Screening Players

Table 70. Newborn Genetic Screening Market: Company Product Type Footprint

Table 71. Newborn Genetic Screening Market: Company Product Application Footprint

Table 72. Newborn Genetic Screening New Market Entrants and Barriers to Market Entry

Table 73. Newborn Genetic Screening Mergers, Acquisition, Agreements, and Collaborations

Table 74. Global Newborn Genetic Screening Consumption Value (USD Million) by Type (2018-2023)

Table 75. Global Newborn Genetic Screening Consumption Value Share by Type (2018-2023)

Table 76. Global Newborn Genetic Screening Consumption Value Forecast by Type (2024-2029)

Table 77. Global Newborn Genetic Screening Consumption Value by Application (2018-2023)

Table 78. Global Newborn Genetic Screening Consumption Value Forecast by Application (2024-2029)

Table 79. North America Newborn Genetic Screening Consumption Value by Type (2018-2023) & (USD Million)

Table 80. North America Newborn Genetic Screening Consumption Value by Type (2024-2029) & (USD Million)

Table 81. North America Newborn Genetic Screening Consumption Value by Application (2018-2023) & (USD Million)

Table 82. North America Newborn Genetic Screening Consumption Value by Application (2024-2029) & (USD Million)

Table 83. North America Newborn Genetic Screening Consumption Value by Country (2018-2023) & (USD Million)

Table 84. North America Newborn Genetic Screening Consumption Value by Country (2024-2029) & (USD Million)

Table 85. Europe Newborn Genetic Screening Consumption Value by Type (2018-2023) & (USD Million)

Table 86. Europe Newborn Genetic Screening Consumption Value by Type (2024-2029) & (USD Million)

Table 87. Europe Newborn Genetic Screening Consumption Value by Application (2018-2023) & (USD Million)

Table 88. Europe Newborn Genetic Screening Consumption Value by Application (2024-2029) & (USD Million)

Table 89. Europe Newborn Genetic Screening Consumption Value by Country (2018-2023) & (USD Million)

Table 90. Europe Newborn Genetic Screening Consumption Value by Country (2024-2029) & (USD Million)

Table 91. Asia-Pacific Newborn Genetic Screening Consumption Value by Type (2018-2023) & (USD Million)

Table 92. Asia-Pacific Newborn Genetic Screening Consumption Value by Type (2024-2029) & (USD Million)

Table 93. Asia-Pacific Newborn Genetic Screening Consumption Value by Application (2018-2023) & (USD Million)

Table 94. Asia-Pacific Newborn Genetic Screening Consumption Value by Application (2024-2029) & (USD Million)

Table 95. Asia-Pacific Newborn Genetic Screening Consumption Value by Region (2018-2023) & (USD Million)

Table 96. Asia-Pacific Newborn Genetic Screening Consumption Value by Region (2024-2029) & (USD Million)

Table 97. South America Newborn Genetic Screening Consumption Value by Type (2018-2023) & (USD Million)

Table 98. South America Newborn Genetic Screening Consumption Value by Type (2024-2029) & (USD Million)

Table 99. South America Newborn Genetic Screening Consumption Value by Application (2018-2023) & (USD Million)

Table 100. South America Newborn Genetic Screening Consumption Value by Application (2024-2029) & (USD Million)

Table 101. South America Newborn Genetic Screening Consumption Value by Country (2018-2023) & (USD Million)

Table 102. South America Newborn Genetic Screening Consumption Value by Country (2024-2029) & (USD Million)

Table 103. Middle East & Africa Newborn Genetic Screening Consumption Value by Type (2018-2023) & (USD Million)

Table 104. Middle East & Africa Newborn Genetic Screening Consumption Value by Type (2024-2029) & (USD Million)

Table 105. Middle East & Africa Newborn Genetic Screening Consumption Value by Application (2018-2023) & (USD Million)

Table 106. Middle East & Africa Newborn Genetic Screening Consumption Value by Application (2024-2029) & (USD Million)

Table 107. Middle East & Africa Newborn Genetic Screening Consumption Value by Country (2018-2023) & (USD Million)

Table 108. Middle East & Africa Newborn Genetic Screening Consumption Value by Country (2024-2029) & (USD Million)

Table 109. Newborn Genetic Screening Raw Material

Table 110. Key Suppliers of Newborn Genetic Screening Raw Materials

List of Figures

Figure 1. Newborn Genetic Screening Picture

Figure 2. Global Newborn Genetic Screening Consumption Value by Type, (USD Million), 2018 & 2022 & 2029

Figure 3. Global Newborn Genetic Screening Consumption Value Market Share by Type in 2022

Figure 4. Dry blood spot tests

Figure 5. Hearing screening tests

Figure 6. CCHD screening tests

Figure 7. Global Newborn Genetic Screening Consumption Value by Type, (USD Million), 2018 & 2022 & 2029

Figure 8. Newborn Genetic Screening Consumption Value Market Share by Application in 2022

Figure 9. Clinical Laboratories Picture

Figure 10. Hospitals Picture

Figure 11. Global Newborn Genetic Screening Consumption Value, (USD Million): 2018 & 2022 & 2029

Figure 12. Global Newborn Genetic Screening Consumption Value and Forecast (2018-2029) & (USD Million)

Figure 13. Global Market Newborn Genetic Screening Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)

Figure 14. Global Newborn Genetic Screening Consumption Value Market Share by Region (2018-2029)

Figure 15. Global Newborn Genetic Screening Consumption Value Market Share by Region in 2022

Figure 16. North America Newborn Genetic Screening Consumption Value (2018-2029) & (USD Million)

Figure 17. Europe Newborn Genetic Screening Consumption Value (2018-2029) & (USD Million)

Figure 18. Asia-Pacific Newborn Genetic Screening Consumption Value (2018-2029) & (USD Million)

Figure 19. South America Newborn Genetic Screening Consumption Value (2018-2029) & (USD Million)

Figure 20. Middle East and Africa Newborn Genetic Screening Consumption Value (2018-2029) & (USD Million)

Figure 21. Global Newborn Genetic Screening Revenue Share by Players in 2022

Figure 22. Newborn Genetic Screening Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022

Figure 23. Global Top 3 Players Newborn Genetic Screening Market Share in 2022

Figure 24. Global Top 6 Players Newborn Genetic Screening Market Share in 2022

Figure 25. Global Newborn Genetic Screening Consumption Value Share by Type (2018-2023)

Figure 26. Global Newborn Genetic Screening Market Share Forecast by Type (2024-2029)

Figure 27. Global Newborn Genetic Screening Consumption Value Share by Application (2018-2023)

Figure 28. Global Newborn Genetic Screening Market Share Forecast by Application (2024-2029)

Figure 29. North America Newborn Genetic Screening Consumption Value Market Share by Type (2018-2029)

Figure 30. North America Newborn Genetic Screening Consumption Value Market Share by Application (2018-2029)

Figure 31. North America Newborn Genetic Screening Consumption Value Market Share by Country (2018-2029)

Figure 32. United States Newborn Genetic Screening Consumption Value (2018-2029) & (USD Million)

Figure 33. Canada Newborn Genetic Screening Consumption Value (2018-2029) & (USD Million)

Figure 34. Mexico Newborn Genetic Screening Consumption Value (2018-2029) & (USD Million)

Figure 35. Europe Newborn Genetic Screening Consumption Value Market Share by Type (2018-2029)

Figure 36. Europe Newborn Genetic Screening Consumption Value Market Share by Application (2018-2029)

Figure 37. Europe Newborn Genetic Screening Consumption Value Market Share by Country (2018-2029)

Figure 38. Germany Newborn Genetic Screening Consumption Value (2018-2029) & (USD Million)

Figure 39. France Newborn Genetic Screening Consumption Value (2018-2029) & (USD Million)

Figure 40. United Kingdom Newborn Genetic Screening Consumption Value (2018-2029) & (USD Million)

Figure 41. Russia Newborn Genetic Screening Consumption Value (2018-2029) & (USD Million)

Figure 42. Italy Newborn Genetic Screening Consumption Value (2018-2029) & (USD Million)

Figure 43. Asia-Pacific Newborn Genetic Screening Consumption Value Market Share by Type (2018-2029)

Figure 44. Asia-Pacific Newborn Genetic Screening Consumption Value Market Share by Application (2018-2029)

Figure 45. Asia-Pacific Newborn Genetic Screening Consumption Value Market Share by Region (2018-2029)

Figure 46. China Newborn Genetic Screening Consumption Value (2018-2029) & (USD Million)

Figure 47. Japan Newborn Genetic Screening Consumption Value (2018-2029) & (USD Million)

Figure 48. South Korea Newborn Genetic Screening Consumption Value (2018-2029) & (USD Million)

Figure 49. India Newborn Genetic Screening Consumption Value (2018-2029) & (USD Million)

Figure 50. Southeast Asia Newborn Genetic Screening Consumption Value (2018-2029) & (USD Million)

Figure 51. Australia Newborn Genetic Screening Consumption Value (2018-2029) & (USD Million)

Figure 52. South America Newborn Genetic Screening Consumption Value Market Share by Type (2018-2029)

Figure 53. South America Newborn Genetic Screening Consumption Value Market Share by Application (2018-2029)

Figure 54. South America Newborn Genetic Screening Consumption Value Market Share by Country (2018-2029)

Figure 55. Brazil Newborn Genetic Screening Consumption Value (2018-2029) & (USD Million)

Figure 56. Argentina Newborn Genetic Screening Consumption Value (2018-2029) & (USD Million)

Figure 57. Middle East and Africa Newborn Genetic Screening Consumption Value Market Share by Type (2018-2029)

Figure 58. Middle East and Africa Newborn Genetic Screening Consumption Value Market Share by Application (2018-2029)

Figure 59. Middle East and Africa Newborn Genetic Screening Consumption Value Market Share by Country (2018-2029)

Figure 60. Turkey Newborn Genetic Screening Consumption Value (2018-2029) & (USD Million)

Figure 61. Saudi Arabia Newborn Genetic Screening Consumption Value (2018-2029) & (USD Million)

Figure 62. UAE Newborn Genetic Screening Consumption Value (2018-2029) & (USD Million)

Figure 63. Newborn Genetic Screening Market Drivers

Figure 64. Newborn Genetic Screening Market Restraints

Figure 65. Newborn Genetic Screening Market Trends

Figure 66. Porters Five Forces Analysis

Figure 67. Manufacturing Cost Structure Analysis of Newborn Genetic Screening in 2022

Figure 68. Manufacturing Process Analysis of Newborn Genetic Screening

Figure 69. Newborn Genetic Screening Industrial Chain

Figure 70. Methodology

Figure 71. Research Process and Data Source